{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:06:00Z","timestamp":1790539560688,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/jp.2014.161","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T13:39:35Z","timestamp":1410442775000},"page":"90-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Spiramycin\/cotrimoxazole versus pyrimethamine\/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy"],"prefix":"10.1038","volume":"35","author":[{"given":"P","family":"Valentini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Buonsenso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Serranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Calzedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Speziale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Masini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"key":"BFjp2014161_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/B0-72-160537-0\/50033-5","volume-title":"Infectious disease of the fetus and newborn infant","author":"JS Remington","year":"2006","unstructured":"Remington JS, McLeod R, Thulliez P, Desmonts G . (2006) Toxoplasmosis In: Remington JS, Klein J, Wilson CB, Baker CJ. (ed) Infectious disease of the fetus and newborn infant. Elsevier Saunders: Philadelphia, 2006 pp 947\u20131092."},{"key":"BFjp2014161_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijmm.2008.10.002","volume":"299","author":"MF Ferreira-da-Silva","year":"2009","unstructured":"Ferreira-da-Silva MF, Takacs AC, Barbosa HS, Gross U, Luder CG . Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite to- bradyzoite conversion at higher rates than fibroblasts. Int J Med Microbiol 2009; 299: 381\u2013388.","journal-title":"Int J Med Microbiol"},{"key":"BFjp2014161_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","volume":"353","author":"D Dunn","year":"1999","unstructured":"Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R . Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829\u20131833.","journal-title":"Lancet"},{"key":"BFjp2014161_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1471-0528.2003.02325.x","volume":"110","author":"European Multicentre Study on Congenital Toxoplasmosis","year":"2003","unstructured":"European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003; 110: 112\u2013120.","journal-title":"BJOG"},{"key":"BFjp2014161_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","volume":"369","author":"R Thiebaut","year":"2007","unstructured":"The SYROCOT Study Group: The SYROCOT Study Group Thiebaut R, The SYROCOT Study Group Leproust S, The SYROCOT Study Group Chene G, The SYROCOT Study Group Gilbert RE . Effectiveness of prenatal treatment for congenital toxoplasmosis: a metaanalysis of individual patients\u2019 data. Lancet 2007; 369: 115\u2013122.","journal-title":"Lancet"},{"key":"BFjp2014161_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1471-0528.2003.02325.x","volume":"110","author":"R Gilbert","year":"2003","unstructured":"Gilbert R, Gras L . Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003; 110: 112\u2013120.","journal-title":"BJOG"},{"key":"BFjp2014161_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1590\/S0036-46652006000200007","volume":"48","author":"MM Reis","year":"2006","unstructured":"Reis MM, Tessaro MM, D\u2019Azevedo PA . Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of motherto-child transmission. Rev Inst Med Trop Sao Paulo 2006; 48: 93\u201398.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"BFjp2014161_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1526-9523(03)00279-4","volume":"48","author":"JA Pinard","year":"2003","unstructured":"Pinard JA, Irvine PJ . Maternal serologic screening for toxoplasmosis. J Midwifery Womens Health 2003; 48: 308\u2013316.","journal-title":"J Midwifery Womens Health"},{"key":"BFjp2014161_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2431-5-21","volume":"5","author":"A Salt","year":"2005","unstructured":"Salt A, Freeman K, Prusa A, Ferret N, Buffolano W, Malm G et al. Determinants of response to a parent questionnaire about development and behaviour in 3 year olds: European multicentre study of congenital toxoplasmosis. BMC Pediatr 2005; 5: 5\u201321.","journal-title":"BMC Pediatr"},{"key":"BFjp2014161_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1056\/NEJM199406303302604","volume":"330","author":"NG Guerina","year":"1994","unstructured":"Guerina NG, Hsu HW, Meissner HC, Maquire JH, Lynfield R, Stechenberg B et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994; 330: 1858\u20131863.","journal-title":"N Engl J Med"},{"key":"BFjp2014161_CR11","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1111\/j.1651-2227.2005.tb01844.x","volume":"94","author":"L Gras","year":"2005","unstructured":"Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatrica 2005; 94: 1721\u20131731.","journal-title":"Acta Paediatrica"},{"key":"BFjp2014161_CR12","first-page":"96S","volume":"65","author":"PA Raeber","year":"1995","unstructured":"Raeber PA, Biedermann K, Just M, Zuber P . Prevention of congenital toxoplasmosis in Europe [in German]. Schweiz Med Wochenschr Suppl 1995; 65: 96S\u2013102S.","journal-title":"Schweiz Med Wochenschr Suppl"},{"key":"BFjp2014161_CR13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/bmj.318.7197.1511","volume":"318","author":"M Wallon","year":"1999","unstructured":"Wallon M, Liou C, Garner P, Peyron F . Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999; 318: 1511\u20131514.","journal-title":"BMJ"},{"key":"BFjp2014161_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/ije\/29.5.941","volume":"29","author":"EC Neto","year":"2000","unstructured":"Neto EC, Anele E, Rubim R, Brites A, Schulte J, Becker D et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 2000; 29: 941\u2013947.","journal-title":"Int J Epidemiol"},{"key":"BFjp2014161_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1017\/S0950268801005775","volume":"127","author":"B Evengard","year":"2001","unstructured":"Evengard B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Te\u00e4r-Fahnehjelm K et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001; 127: 121\u2013127.","journal-title":"Epidemiol Infect"},{"key":"BFjp2014161_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0002-9378(99)70224-3","volume":"180","author":"W Foulon","year":"1999","unstructured":"Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children\u2019s sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410\u2013415.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp2014161_CR17","first-page":"113","volume":"127","author":"R Gilbert","year":"2001","unstructured":"Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect 2001; 127: 113\u2013120.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"BFjp2014161_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10096-008-0612-5","volume":"28","author":"P Valentini","year":"2009","unstructured":"Valentini P, Annunziata ML, Angelone DF, Masini L, De Santis M, Testa A et al. Role of spiramycin\/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy. Eur J Clin Microbiol Infect Dis 2009; 28 (3): 297\u2013300.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFjp2014161_CR19","first-page":"193","volume":"15","author":"D Serranti","year":"2011","unstructured":"Serranti D, Buonsenso D, Valentini P . Congenital toxoplasmosis treatment. Eur Rev Med Pharmacol Sci 2011; 15: 193\u2013198.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"BFjp2014161_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/BF01701522","volume":"15","author":"M Lebech","year":"1996","unstructured":"Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Microbiol Infect Dis 1996; 15: 799\u2013805.","journal-title":"Eur J Microbiol Infect Dis"},{"key":"BFjp2014161_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/096914139600300406","volume":"3","author":"A Eskild","year":"1996","unstructured":"Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig LS . Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen 1996; 3: 188\u2013194.","journal-title":"J Med Screen"},{"key":"BFjp2014161_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/ije\/30.6.1303","volume":"30","author":"RE Gilbert","year":"2001","unstructured":"Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT . Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001; 30: 1303\u20131308.","journal-title":"Int J Epidemiol"},{"key":"BFjp2014161_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/ije\/30.6.1309","volume":"30","author":"L Gras","year":"2001","unstructured":"Gras L, Gilbert RE, Ades AE, Dunn DT . Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001; 30: 1309\u20131313.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"BFjp2014161_CR24","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","volume":"112","author":"M Soheilian","year":"2005","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M, Dehghan MH, Yazdani S, Behboudi H et al. Prospective Randomized Trial of Trimethoprim\/Sulfamethoxazole versus Pyrimethamine and Sulfadiazine in the Treatment of Ocular Toxoplasmosis. Ophthalmology 2005; 112 (11): 1876\u20131882.","journal-title":"Ophthalmology"},{"key":"BFjp2014161_CR25","first-page":"135","volume-title":"Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy","author":"PL Grossman","year":"1978","unstructured":"Grossman PL, Krahenbuhl JL, Remington JS . (1978). In vivo and in vitro effects of trimethoprim and sulfamethoxazole on Toxoplasma infection In: Siegenhaler W, Luthy R (ed) Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy. American Society for Microbiology: Zurich, 1978 pp 135\u2013137."},{"key":"BFjp2014161_CR26","first-page":"307","volume":"10","author":"BT Nguyen","year":"1975","unstructured":"Nguyen BT, Stadtsbaeder S . In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii. Path Europ 1975; 10: 307\u2013315.","journal-title":"Path Europ"},{"key":"BFjp2014161_CR27","first-page":"956","volume":"97","author":"J Arens","year":"2007","unstructured":"Arens J, Barnes K, Crowley N, Maartens G . Treating AIDS-associated cerebral toxoplasmosis\u2014pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. S Afr Med J 2007; 97: 956\u2013958.","journal-title":"S Afr Med J"},{"key":"BFjp2014161_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ, Brinkman CJ, Baarsma GS, Boen-Tan TN et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol 1993; 115: 517\u2013523.","journal-title":"Am J Ophthalmol"},{"key":"BFjp2014161_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(92)31873-1","volume":"99","author":"EM Opremcak","year":"1992","unstructured":"Opremcak EM, Scales DK, Sharpe MR . Trimethoprim-sulfame thoxazole therapy for ocular toxoplasmosis. Ophthalmology 1992; 99: 920\u2013925.","journal-title":"Ophthalmology"},{"key":"BFjp2014161_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","volume":"134","author":"GN Holland","year":"2002","unstructured":"Holland GN, Lewis KG . An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102\u2013114.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"BFjp2014161_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","volume":"134","author":"C Silveira","year":"2002","unstructured":"Silveira C, Belfort R Jr, Muccioli C, Holland GN, Victora CG, Horta BL et al. The Effect of Long-term Intermittent Trimethoprim\/Sulfamethoxazole Treatment on Recurrences of Toxoplasmic Retinochoroiditis. Am J Ophthalmol 2002; 134 (1): 41\u201346.","journal-title":"Am J Ophthalmol"},{"key":"BFjp2014161_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/bmj.294.6563.42","volume":"294","author":"R Wise","year":"1987","unstructured":"Wise R . Antibiotics. BMJ 1987; 294: 42\u201346.","journal-title":"BMJ"},{"key":"BFjp2014161_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0890-6238(01)00178-2","volume":"15","author":"AE Czeizel","year":"2001","unstructured":"Czeizel AE, Rockenbauer M, S\u00f8rensen HT, Olsen J . The teratogenic risk of trimethoprim-sulfonamides: a population based case\u2013control study. Reprod Toxicol 2001; 15: 637\u2013646.","journal-title":"Reprod Toxicol"},{"issue":"3","key":"BFjp2014161_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF03256651","volume":"2","author":"WS Lim","year":"2003","unstructured":"Lim WS, Macfarlane JT, Colthorpe CL . Treatment of community-acquired lower respiratory tract infections during pregnancy. Am J Respir Med. 2003; 2 (3): 221\u2013233.","journal-title":"Am J Respir Med."},{"issue":"8162","key":"BFjp2014161_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(80)90739-4","volume":"1","author":"RJ Leeming","year":"1980","unstructured":"Leeming RJ . Co-trimoxazole and phenylalanine metabolism. Lancet 1980; 1 (8162): 255\u2013256.","journal-title":"Lancet"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp2014161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2014161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2014161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:15:19Z","timestamp":1647609319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp2014161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFjp2014161"],"URL":"https:\/\/doi.org\/10.1038\/jp.2014.161","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]},"assertion":[{"value":"14 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}